The Latest Breaking News on Pharma

European countries could stretch out limited supplies of the monkeypox vaccine by administering smaller doses of the shot, the European Medicines Agency (EMA) said on Friday.

The European Medicines Agency said a smaller dose of the monkeypox vaccine appears to still be effective and can be used to stretch the current supply by five times, echoing a recommendation made earlier this month by the U.S. Food and Drug Administration

The Oak Park Democrat continues to accept campaign money from Johnson & Johnson, 1 of 4 companies paying $26 billion to settle suits accusing them of fueling the crisis. He’s not the only Illinois official doing so.

Drug traffickers have gone hi-tech and are using dark web, social media and crypto currency to carry on their activities clandestinely, reveals a police investigation following a drug bust

The US Food and Drug Administration (FDA) has accepted for filing Krystal Biotech’s (NASDAQ:KRYS) Biologics License Application (BLA) for its lead candidate B-VEC in the treatment of patients with dystrophic epidermolysis bullosa (DEB). The regulatory agency has granted  Priority Review designation and assigned a target actin date of February 17,…

Psychedelics therapeutics biotech company Awakn Life Sciences Corp. (OTCQB: AWKNF) has signed what constitutes its first licensing partnership deal in Canada.

PharmAla Biotech Holdings Inc, the biotech company producing MDXX class molecules has released a large-scale batch of its proprietary MDMA API, “Laneo,” becoming the first publicly-traded venture to produce the drug within Good Manufacturing Processes (GMP) in such a major amount.

Renowned biopharmaceutical company AbbVie (ABBV) continued its business momentum in the second quarter with considerable progress for its new products and indications. Moreover, the company is well-positioned to benefit from significant advances across its pipeline. Given its diversified business model, strong financials, high profitability, discounted valuation, and solid growth prospects,…

Despite the market volatility and odds of a recession, the pharma industry is well-positioned to grow due to the aging global population and the increasing chronic diseases. Therefore, investing in quality pharma stocks Pfizer (PFE) and Merck & Co. (MRK) could be wise. Read more.

Petitioner cites case of Dolo 650, says any dosage beyond 500 mg is outside regulation

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has initiated a new Phase 3 trial to investigate the efficacy and safety of Epidiolex (cannabidiol), known as Epidyolex in Europe, in children and adolescents with e